Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz

Patent Law

: IPBiz

Kanzius obtains US 7,510,555

By Lawrence B. Ebert, Esq.

A search of the USPTO database on 25 May 09 revealed one patent issued to John Kanzius, US 7,510,555 issued on March 31, 2009. The first claim states:

A method for killing or damaging target cells in a patient, comprising:

introducing into the patient RF absorption enhancers capable of selectively binding to the target cells and further capable of generating sufficient heat to kill or damage the bound target cells by heat generated solely by the application of an RF field generated by an RF signal between a transmission head and a reception head that is different from the transmission head;

arranging the transmission and reception heads on opposite sides of a portion of the patient for treatment; and

irradiating the portion of the patient between the transmission and reception heads containing RF absorption enhancers with an RF field to kill or damage the target cells from the heat generated by the RF absorption enhancers.

Claim 67 states: The method according to any of claims 1-10, 22-24, 44, 46-50, 62 and 63, wherein the RF signal comprises a signal having a frequency component at one of about 13.56 MHz and about 27.12 MHz for heating the RF absorption enhancers.

The related application section states: This application claims priority to, and the benefits of, provisional application Ser. No.: 60/569,348 filed on May 7, 2004, which is entitled System and Method For RF-Induced Hyperthermia, and which is incorporated herein by reference. This application is also a continuation in part of and claims priority to non-provisional application Ser. No.: 10/969,477 filed on Oct. 20, 2004, which is also entitled System and Method for RF-Induced Hyperthermia, which is currently pending, and which is incorporated herein by reference. This application is also related to U.S. patent application Ser. No. 11/050,478, filed herewith and entitled Systems and Methods for Combined RF-Induced Hyperthermia and Radioimmunotherapy, which is currently pending, and related to U.S. patent application Ser. No. 11/050,481, filed herewith and entitled Systems and Methods for RF-Induced Hyperthermia Using Biological Cells and Nanoparticles as RF Enhancer Carriers, which is currently pending, both of which are incorporated herein by reference.

See also

8 March 09 post titled
Kanzius IP concerns patent applications, not issued patents, which is herewith updated to acknowledge the '555 to sole inventor Kanzius (now deceased)

article by Jennifer Stacy: Kanzius cancer work continues: The latest steps toward a cure

Full post as published by IPBiz on May 25, 2009 (boomark / email).